Liling Zhang
Clinical trials sponsored by Liling Zhang, explained in plain language.
-
New drug combo aims to control rare blood cancer in early trial
Disease control Recruiting nowThis study tests whether combining two drugs, duvelisib and chidamide, can safely control peripheral T-cell lymphoma in people who are newly diagnosed. About 36 adults aged 18 to 70 will receive the combination. The goal is to see how well the drugs shrink tumors and how long the…
Phase: PHASE2 • Sponsor: Liling Zhang • Aim: Disease control
Last updated May 26, 2026 04:30 UTC
-
Radiation boosts immunotherapy in Tough-to-Treat lymphoma
Disease control Recruiting nowThis study tests whether adding a short course of radiation to the drug glofitamab can improve outcomes for people with a type of aggressive lymphoma (DLBCL) that has come back or not responded to treatment, especially when the cancer is large. About 40 adults aged 18-75 will rec…
Phase: PHASE2 • Sponsor: Liling Zhang • Aim: Disease control
Last updated May 22, 2026 14:02 UTC